Abeona Therapeutics News

Abeona Therapeutics Is Maintained at Overweight by Cantor Fitzgerald

Abeona Therapeutics Is Maintained at Overweight by Cantor Fitzgerald

Dow JonesMay 16 23:23

Cantor Fitzgerald Maintains Overweight on Abeona Therapeutics, Lowers Price Target to $21

Cantor Fitzgerald analyst Kristen Kluska maintains Abeona Therapeutics (NASDAQ:ABEO) with a Overweight and lowers the price target from $28 to $21.

BenzingaMay 16 23:14

Abeona Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 360.53% Cantor Fitzgerald $28 → $21 Maintains Overweight 04/23/2024 689.47% Cantor Fitzgerald →

BenzingaMay 16 23:11

Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...

Yahoo FinanceMay 16 15:01

Q1 2024 Abeona Therapeutics Inc Earnings Call

Yahoo FinanceMay 16 14:17

Abeona Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results.

Abeona Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results.

BenzingaMay 16 00:29

ABEONA THERAPEUTICS INC. Q1 Loss Increases, Misses Estimates

RTTNewsMay 15 20:07

Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May Is Expected To Provide Cash Runway Into 2026

Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May

BenzingaMay 15 19:43

Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate

Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate

BenzingaMay 15 19:40

Abeona Therapeutics | 10-Q: Quarterly report

SEC announcementMay 15 19:40 · Announcements

Press Release: Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, ex

Dow JonesMay 15 19:30

Abeona Therapeutics 1Q Loss/Shr $1.16 >ABEO

Abeona Therapeutics 1Q Loss/Shr $1.16 >ABEO

Dow JonesMay 15 19:30

Plunge for Elodie Raises $2.5M+ for Life-Saving Rare Disease Research in Just 7 Years

Celebrities, sports teams, schools and supporters across 20+ locations worldwide take polar plunges to raise awareness and funds for rare genetic skin disorder called EBNEW YORK, May 7, 2024 /PRNewsw

PR NewswireMay 7 20:00

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, May 07, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in

GlobeNewswireMay 7 19:30

Abeona Therapeutics Shares Rise After Underwritten Offering Gets Priced

By Dean Seal Shares of Abeona Therapeutics jumped after the company's underwritten offering was priced to raise $75 million. The stock was up 21% at $4.92 in early trading. Shares are about 2% below

WSJMay 3 22:42

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

CLEVELAND, May 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) ("Abeona" or the "Company") today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock and, in

GlobeNewswireMay 3 19:30

Abeona Therapeutics(ABEO.US) Officer Buys US$32,000 in Common Stock

$Abeona Therapeutics(ABEO.US)$ Officer Seshadri Vishwas purchased 10,000 shares of common stock on Apr 25, 2024 at an average price of $3.2 for a total value of $32,000.Source: Announcement What is st

Futu NewsApr 29 21:11

Abeona Therapeutics(ABEO.US) Director Buys US$24,764 in Common Stock

$Abeona Therapeutics(ABEO.US)$ Director Charles Faith L. purchased 7,550 shares of common stock on Apr 26, 2024 at an average price of $3.28 for a total value of $24,764.Source: Announcement What is s

Futu NewsApr 29 21:11

Abeona Therapeutics(ABEO.US) Officer Buys US$27,864 in Common Stock

$Abeona Therapeutics(ABEO.US)$ Officer O'Malley Brendan M. purchased 8,600 shares of common stock on Apr 25, 2024 at an average price of $3.24 for a total value of $27,864.Source: Announcement What is

Futu NewsApr 26 21:11

Abeona Therapeutics(ABEO.US) Officer Buys US$17,609.12 in Common Stock

$Abeona Therapeutics(ABEO.US)$ Officer Vazzano Joseph Walter purchased 5,608 shares of common stock on Apr 25, 2024 at an average price of $3.14 for a total value of $17,609.12.Source: Announcement Wh

Futu NewsApr 26 21:11